CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Bill Anderson

CEO, Bayer

Search every verified Bill Anderson interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. On October 8, 2026, Bayer CEO Bill Anderson appeared in an episode of the company's "Science Is Boss" series, where he discussed stroke prevention with Bayer scientist Stefan Heitmeier. Anderson highlighted the challenges of developing stroke treatments, noting that interventions to reduce clot risk can increase bleeding risk. He described the scientific process of identifying a novel target, including testing thousands of molecules over many years, and emphasized the urgent unmet medical need in secondary stroke prevention. Anderson also spoke about the broader impact of stroke, citing that it occurs globally every three seconds and places a significant burden on families and healthcare systems. He praised the persistence and teamwork of researchers like Heitmeier, connecting their work to Bayer's mission of "health for all, hunger for none." The conversation focused on the scientific distinction between beneficial and harmful clots, with Anderson explaining the strategy of targeting specific proteins to prevent pathological clots while preserving the body's ability to form necessary ones.

Recent appearances

Verified interview transcripts

Notable quotes

“We've said very clearly, if there's not a solution to the litigation problem on glyphosate, there won't be American-produced glyphosate. ... We produce roughly half the glyphosate for the world and the other half comes from Asia. ... Bayer's had well over 100,000 lawsuits. And how many lawsuits the Asian manufacturers have had? Zero. So this is basically America trial lawyers vs. America.”

“Raise your hand if you think the litigation industry is costing your household, let's say, do you think $1,000? Who thinks it's costing your household $1,000 or more per year? ... $4300 per U.S. household, per year. And a lot of people in this room are probably above average, which means you're gonna be paying more than $4300.”

“We have a product that has been available for 50 years in the U.S. and around the world. It's been probably the most thoroughly studied crop protection chemical of all time. It's been reviewed and approved and re-reviewed by the U.S. EPA, the European Food Safety Authority, the English authorities, Australian, New Zealand, Japan, and so on. There's not a single regulatory body in the world that has labeled it as carc”

“In February, Monsanto announced a class settlement which received preliminary approval in early March. We've seen numerous plaintiff firms, even firms who traditionally oppose class settlements, recommend the settlement to their clients. Further, we're pleased that the United States Supreme Court will hear our case with oral arguments scheduled for next Monday. This is a big milestone for American farmers and a lot i”

“I want to acknowledge that we're once again proposing paying out the minimum dividend. As we've previously communicated, this is not an easy step, but it remains the right one for the company's financial future. As we consider our dividend policy going forward, we'll look carefully at the company's capital allocation strategy that's given our cash and debt position.”

“Team Bayer registered sales of 45.6 billion euros. Our core earnings per share came in at 491. We generated €2.1 billion of free cash flow and we reduced our net financial debt to 29.8 billion.”

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →